CD86 and neoplasm: Strikingly, the higher dose of exosomes derived from LOAd703-infected tumor cells could mature DCs, as seen by upregulation of MHC class I (HLA-ABC), CD86, and CD83 (p ≤ 0.05) (Figure 7).